Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Article
Molecular cancer research : MCR
2020
Correction: Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer.
PubMed ↗
Publisher ↗
No numbers read from the abstract.
Not cited yet
Correction: Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer. | OpenQuestion